Vanqua Bio
- Founded: 2019
- Location: Chicago, IL
- Employee range: 11 - 50
- Clinical stage: Clin0
- Therapy area: Parkinson's, Gaucher disease
- Drug types: NEU
- Lead product: Undisclosed
- Product link: https://www.vanquabio.com/science/
- Funding: $85M B Sep 2021
- Investors: OrbiMed, Omega Funds, Surveyor Capital, Avoro Ventures, Casdin Capital, Pontifax, Eli Lilly, Logos Capital, Osage University Partners
vanquabio.com linkedin.com job board
Short description:
Small Molecules Targeting Neuro Indications
Drug notes:
Also RD Parkinson's, Lewy body dementia; 2 additional undisclosed programs RD Alzheimer's, Parkinson's, neurodegenerative diseases
Long description:
Contact us to add description: recruit@workinbiotech.com
Jobs:
© 2024 Work In Biotech LLC
Personal dataTerms of ServicePrivacy PolicyContact: recruit@workinbiotech.com
Personal dataTerms of ServicePrivacy PolicyContact: recruit@workinbiotech.com